USPTO 2015–2025 USPTO PatentsView Foreign Corporation

National Institute of Biological Sciences, Beijing

USPTO PatentsView assignee record - 20 granted patents across 9 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, National ranks #14,800 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 9 technology areas.

#14,800
of 49,997 US assignees by volume
48th percentile
by Innovation Score (34.6/100)
17.6
avg claims per patent
+86%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14800 · Foreign Corporation #14,800 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 20 grants
  • MID-PACK #14,800/49,997
  • PHOTO-FINISH Nagaoka University…
  • CPC-NARROW A61P · 9 areas
  • INNOV-THIN 34.6/100
  • CLAIMS-RICH 17.6 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +86% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nagaoka University of Technology (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How National’s 34.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around National

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows National's Innovation Score is 34.6/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for National?

Each dot is one of National’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). National’s own 17.6 claims/patent is ABOVE the 10.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

National vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 19.919.92020.1 5101520 Granted patents (volume) Avg claims / patent NTT Research, Inc. - 20, 17.35NTT ResearchNagaoka University of Technology - 20, 10.55Nagaoka Universit…Najing Technology Corporation Ltd. - 20, 17.7Najing TechnologyNational Institute Of Technology - 20, 9.6National Institut…National Institute of Standards and Technology - 20, 17.6National Institut…National Institutes of Biomedical Innovation, Health and Nutrition - 20, 9.6National Institut…National University Corporation Tokyo University of Marine Science and Technology - 20, 8National Universi…Nautilus True, LLC - 20, 16.25Nautilus TrueNational Institute of Biological Sciences, Beijing - 20, 17.55National Institut…
National vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where National's grants concentrate

National Institute of Biological Sciences, Beijing is a focused PatentsView assignee: 9 CPC subclasses with 90% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (5 grants) versus a trough of 1 in 2015. By volume, National sits between NTT Research, Inc. and Nautilus True, LLC.

National's three-year grant acceleration

National Institute of Biological Sciences, Beijing shows 4 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at National's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows National holds 20 patents at rank #14,801, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near National

By rank, the assignees closest to #14,801 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in National's primary technology class.

National's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 48th percentile higher than 48% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 2015201720182020202120222023 2
USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
National Institute of Biological Sciences, Beijing patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 5.0%
2017 3 15.0%
2018 3 15.0%
2020 4 20.0%
2021 5 25.0%
2022 2 10.0%
2023 2 10.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

National Institute of Biological Sciences, Beijing's patent record in context - here's where to go next.

  • National Institute of Biological Sciences, Beijing's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 90% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #14,800 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare National Institute of Biological Sciences, Beijing against NTT Research, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 34.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.